Oliver Kepp Selected Research

Oliver Kepp Research Topics

Disease

127	Neoplasms (Cancer) 10/2022 - 04/2003
13	Necrosis 01/2019 - 04/2009
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 03/2010
6	Lung Neoplasms (Lung Cancer) 01/2022 - 08/2012
6	Carcinoma (Carcinomatosis) 02/2014 - 06/2012
5	Carcinogenesis 01/2022 - 03/2012
5	Infections 12/2021 - 03/2009
4	Residual Neoplasm 01/2021 - 06/2010
4	Breast Neoplasms (Breast Cancer) 01/2019 - 05/2012
4	Fibrosarcoma 01/2019 - 06/2013
4	Tetraploidy 02/2014 - 04/2009
3	Colonic Neoplasms (Colon Cancer) 01/2022 - 02/2014
3	Melanoma (Melanoma, Malignant) 01/2022 - 01/2018
3	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 05/2012
3	Lymphoma (Lymphomas) 10/2021 - 01/2019
3	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 01/2013
3	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2015
2	COVID-19 12/2021 - 01/2020
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 01/2020
2	Cystic Fibrosis (Mucoviscidosis) 11/2019 - 01/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2016 - 09/2013
2	Polyploidy 02/2014 - 06/2012
2	Inflammation (Inflammations) 09/2013 - 03/2012
2	Cadaver (Cadavers) 10/2010 - 06/2010

Drug/Important Bio-Agent (IBA)

19	Adenosine Triphosphate (ATP)IBA 01/2022 - 10/2009
18	AntigensIBA 01/2022 - 10/2008
18	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2008
18	CalreticulinIBA 01/2022 - 02/2009
16	AnthracyclinesIBA 01/2021 - 10/2008
13	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 06/2012
11	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 03/2010
10	HMGB1 Protein (HMG1)IBA 01/2022 - 10/2008
9	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 06/2010
8	Phosphotransferases (Kinase)IBA 01/2021 - 10/2009
6	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2017
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 04/2009
6	VaccinesIBA 01/2020 - 03/2012
5	CarcinogensIBA 01/2021 - 09/2012
5	CrizotinibIBA 01/2021 - 01/2019
5	Peptides (Polypeptides)IBA 01/2020 - 01/2015
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2014
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2017
4	Histones (Histone)IBA 01/2021 - 04/2009
4	Pattern Recognition ReceptorsIBA 01/2021 - 02/2010
4	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 03/2011
4	Pharmaceutical PreparationsIBA 01/2020 - 06/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 06/2013
3	InterferonsIBA 01/2022 - 03/2014
3	AntibodiesIBA 01/2022 - 01/2019
3	LigandsIBA 01/2021 - 10/2010
3	ChromatinIBA 12/2019 - 01/2013
3	InflammasomesIBA 11/2017 - 03/2012
3	Digoxin (Digitek)FDA LinkGeneric 02/2013 - 07/2012
3	Small Interfering RNA (siRNA)IBA 07/2010 - 03/2009
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2022 - 04/2015
2	Interferon Type IIBA 01/2022 - 11/2014
2	CytokinesIBA 01/2022 - 03/2014
2	Local AnestheticsIBA 01/2022 - 01/2021
2	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 10/2021
2	Activating Transcription Factor 6IBA 01/2022 - 01/2018
2	Coenzyme A (CoA)IBA 01/2022 - 01/2019
2	X-Box Binding Protein 1IBA 01/2022 - 01/2018
2	Activating Transcription Factor 4IBA 01/2022 - 01/2018
2	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2019
2	Immunoglobulin G (IgG)IBA 12/2021 - 06/2013
2	Annexin A1IBA 01/2021 - 01/2019
2	Oleic Acid (Oleate)IBA 01/2021 - 04/2015
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021 - 11/2015
2	Green Fluorescent ProteinsIBA 01/2021 - 01/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 06/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2020
2	Recombinant ProteinsIBA 01/2020 - 06/2013
2	PM 01183IBA 01/2020 - 01/2019
2	Adenosine (Adenocard)FDA LinkGeneric 11/2017 - 03/2014
2	NucleotidesIBA 11/2017 - 10/2009
2	Serine-Threonine Kinase 3IBA 01/2017 - 06/2016
2	Caspase 3 (Caspase-3)IBA 06/2016 - 03/2012
2	Cytostatic AgentsIBA 12/2015 - 03/2011
2	Therapeutic UsesIBA 11/2015 - 06/2010
2	LTX-315IBA 09/2015 - 01/2015
2	Purinergic Receptors (Receptors, Purine)IBA 04/2013 - 05/2012
2	Cardiac GlycosidesIBA 02/2013 - 12/2012
2	pyrazolanthroneIBA 01/2013 - 06/2012
2	Cytotoxins (Cytolysins)IBA 08/2012 - 10/2010
2	InterleukinsIBA 03/2012 - 03/2010
2	Toll-Like Receptor 4IBA 04/2009 - 10/2008
1	Arachidonic Acid (Vitamin F)IBA 10/2022
1	Coenzyme A Ligases (Acid-Thiol Ligases)IBA 10/2022
1	Poly (ADP-Ribose) Polymerase-1IBA 01/2022
1	Drug CombinationsIBA 01/2022
1	Anesthetics (Anesthetic Agents)IBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Pantothenic Acid (Calcium Pantothenate)FDA Link 01/2022

Therapy/Procedure

38	Therapeutics 01/2022 - 07/2008
33	Drug Therapy (Chemotherapy) 01/2022 - 09/2009
15	Immunotherapy 01/2022 - 12/2014
9	Radiotherapy 01/2022 - 10/2008
3	Photochemotherapy (Photodynamic Therapy) 01/2022 - 01/2018
2	Intravenous Injections 01/2021 - 10/2020
2	Adjuvant Chemotherapy 11/2015 - 05/2012